Vistagen Therapeutics VTGN
NASDAQ VTGN
$0.31 +0.01 (+3.33%)
At close: Sep 30, 2026 · 4:00 PM EDT

Vistagen Therapeutics (VTGN) Receivables - Net (2011 - 2021)

Updated

Vistagen Therapeutics' Receivables - Net was $40,600 in fiscal Q4 2021 (quarter ended Mar 31, 2021).

Analysis

Vistagen Therapeutics (VTGN) Receivables - Net (2011 - 2021) Analysis & Trends

From fiscal Q4 2011 onward, Vistagen Therapeutics has reported Receivables - Net for 8 quarters.

  • The fiscal Q4 2021 figure marks the highest quarterly Receivables - Net since fiscal Q3 2017.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Vistagen Therapeutics 13.76 Mn 13.76 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2021 40,600.00
Dec 31, 2016 1.25 Mn
Mar 31, 2015 194,900.00
Mar 31, 2012 106,200.00
Dec 31, 2011 7,779.00
Sep 30, 2011 127,058.00
Jun 30, 2011 148,528.00
Mar 31, 2011 42,200.00
API Access

Vistagen Therapeutics Receivables - Net API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-net&ticker=VTGN&period=max&api_key=YOUR_API_KEY